Such regulatory intervention is probably not caused by bradykinin-mediated HAE attacks, as bradykinin stimulates CXCL8 (Koyama et al., 2000) or MMP9 (Yang et al., 2022) expression which is not apparently the case in HAE patients, and other factors must be considered. The gene discussed is MMP9; the disease is hereditary angioedema.